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invBACKGROUND Although recommended in guidelines for the management of coronary heart disease (CHD),
concerns have been raised about the applicability of evidence from existing meta-analyses of exercise-based cardiac
rehabilitation (CR).
OBJECTIVES The goal of this study is to update the Cochrane systematic review and meta-analysis of exercise-based
CR for CHD.
METHODS The Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, CINAHL, and Science Citation Index
Expanded were searched to July 2014. Retrieved papers, systematic reviews, and trial registries were hand-searched.
We included randomized controlled trials with at least 6 months of follow-up, comparing CR to no-exercise controls
following myocardial infarction or revascularization, or with a diagnosis of angina pectoris or CHD deﬁned by angiog-
raphy. Two authors screened titles for inclusion, extracted data, and assessed risk of bias. Studies were pooled using
random effects meta-analysis, and stratiﬁed analyses were undertaken to examine potential treatment effect modiﬁers.
RESULTS A total of 63 studies with 14,486 participants with median follow-up of 12 months were included. Overall, CR
led to a reduction in cardiovascular mortality (relative risk: 0.74; 95% conﬁdence interval: 0.64 to 0.86) and the risk of
hospital admissions (relative risk: 0.82; 95% conﬁdence interval: 0.70 to 0.96). There was no signiﬁcant effect on total
mortality, myocardial infarction, or revascularization. The majority of studies (14 of 20) showed higher levels of health-
related quality of life in 1 or more domains following exercise-based CR compared with control subjects.
CONCLUSIONS This study conﬁrms that exercise-based CR reduces cardiovascular mortality and provides important
data showing reductions in hospital admissions and improvements in quality of life. These beneﬁts appear to be
consistent across patients and intervention types and were independent of study quality, setting, and publication date.
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2W ith increasing numbers of peo-ple living longer with symptom-atic coronary heart disease
(CHD), the effectiveness and accessibility of
health services for people with CHD have
never been more important. Cardiac rehabil-
itation (CR) programs are recognized as inte-
gral to comprehensive care of CHD patients
and have been given a Class I recommenda-
tion from the American Heart Association,
the American College of Cardiology, and the
European Society of Cardiology, with exer-
cise therapy consistently identiﬁed as a
central element (1–4). Although exercise
training remains a cornerstone intervention,
international guidelines consistently recom-
mend the provision of comprehensive reha-bilitation that includes education and psychological
input focusing on health and life-style behavior
change, risk factor modiﬁcation, and psychosocial
well-being (1–3).SEE PAGE 13The ﬁrst systematic reviews and meta-analyses of
exercise-based CR by Oldridge et al. (5) and O’Connor
et al. (6) were published more than 20 years ago,
showing a 20% to 25% reduction in all-cause and car-
diovascular (CV) mortality on the basis of data from 22
randomized controlled trials (RCTs) in over 4,300 pa-
tients. Although there have been more recent updates
to these meta-analyses (7–9), concerns have been
raised about the applicability of their results to policy
planning and the provision of CR services (10,11). It has
been argued that major advances in CHD medical
management may have led to a reduction in the in-
cremental effect on mortality of exercise-based CR
compared with usual care alone. Other concerns have
included the inclusion of small, poor-quality RCTs,
which may have resulted in overestimation of the
beneﬁts of CR, and the almost exclusive recruitment of
low-risk, middle-aged, post-myocardial infarction
(MI) men in early trials, thereby reducing the general-
izability of their ﬁndings to the broader population of
CHD patients (12). Our aim was to systematically up-
date existing meta-analyses to reassess the effects of
exercise-based CR in patients with CHD in terms of
mortality, morbidity, health-related quality of lifend Prof. Thompson were authors of the original Cochrane revie
a number of other Cochrane cardiac rehabilitation reviews. The
not necessarily those of the NHS, the NIHR, or the Department o
tionships relevant to the contents of this paper to disclose.
received July 14, 2015; revised manuscript received October 12,(HRQL), and cost-effectiveness. We also sought to
explorewhether effects vary with patient casemix, the
nature of CR programs, and study characteristics.
METHODS
We conducted and reported this systematic review in
accordance with the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses)
statement (13) and the Cochrane Handbook for
Interventional Reviews (14). The protocol was pub-
lished on the Cochrane Database of Systematic
Reviews (2001) (15).
DATA SEARCHES AND SOURCES. Search terms from
the 2011 Cochrane review (9) were updated and
CENTRAL (Cochrane Central Register of Controlled
Trials), DARE (Database of Abstracts of Reviews of
Effects), HTA (Health Technology Assessment),
MEDLINE and Medline in Process (Ovid), EMBASE
(Ovid), and CINAHL (Cumulative Index to Nursing and
Allied Health Literature) Plus (EBSCO) were searched
to July 2014. Conference proceedings were searched
on the Web of Science Core Collection (Thomson
Reuters) (1970 to June 2014), and bibliographies of
systematic reviews and trial registers (the World
Health Organization [WHO]’s International Clinical
Trials Registry Platform [ICTRP] and Clinicaltrials.gov)
were hand-searched. No language or other limitations
were imposed (see Online Appendix).
STUDY SELECTION. Randomized controlled trials
were sought that compared exercise-based CR with a
control and had a follow-up period of at least 6months.
Exercise-based CR was deﬁned as a supervised or un-
supervised inpatient, outpatient, community-based,
or home-based intervention that included some form
of exercise training, either alone or in addition to
psychosocial and/or educational interventions. The
comparator could include standard medical care and
psychosocial and/or educational interventions, but
not any structured exercise training. We included pa-
tients irrespective of sex or age who had an MI, had
undergone revascularization (coronary artery bypass
grafting [CABG] or percutaneous coronary interven-
tion [PCI]), or who have angina pectoris or CHD deﬁned
by angiography. Finally, studies needed to report 1 or
more of the following outcomes: total or CV mortality;
fatal or nonfatal MI; revascularizations (CABG or PCI);w; and Prof. Taylor and Drs. Rees and Zwisler are
views expressed in this publication are those of the
f Health in England. Ms. Martin has reported that she
2015, accepted October 14, 2015.
FIGURE 1 Summary of Study Selection Process
RCTs included from 2011 Cochrane
review
N = 47
(N = 81 publications)
Titles identified from electronic bibliographies &
screened for retrieval
N = 11,028
Excluded
N = 10,937
Potentially appropriate full-text publications
retrieved for full evaluation
N = 91
RCTs from updated search
N = 16
(N = 21 publications)
Excluded
-
-
-
2 ongoing studies
3 studies awaiting classification
65 excluded
follow-up < 6 months N = 11;
inappropriate comparator N=12;
inappropriate outcomes N=16;
inappropriate  randomization N=15;
inappropriate intervention N=7;
inappropriate population N=2;
population had previously received CR N=2
Total RCTs included in review
N = 63
(N = 102 Publications)
The 63 studies in this review included 47 studies (81 publications) from the 2011 version of the review, and a further 16 studies (21 publications) identiﬁed
from the updated searches. RCT ¼ randomized controlled trial.
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3hospitalizations; HRQL, assessed using validated in-
struments; or costs and cost-effectiveness. Two re-
viewers (L.A. and R.S.T.) independently assessed all
identiﬁed titles/abstracts for possible inclusion, with
any disagreements resolved by discussion. Where
necessary, studies were translated into English.
DATA EXTRACTION AND MANAGEMENT. One
reviewer (L.A.) extracted study and patient charac-
teristics, intervention and comparator details, and
outcome data from included studies using a stan-
dardized data collection form. A second author
(R.S.T.) checked for accuracy, and disagreements
were resolved by consensus. Duplicate publications
of the same study were assessed for additional data
and authors were contacted, where necessary, to
provide additional information.
ASSESSMENT OF RISK OF BIAS AND OVERALL
QUALITY OF EVIDENCE. Risk of bias of included
studies was assessed using the Cochrane Collabo-
ration’s core risk of bias items (14) and 3 further
items deemed relevant to this review. GRADEProﬁlersoftware (16) was used to assess the overall quality of
evidence for each outcome collected (17) (see the
Online Appendix for full details).
DATA SYNTHESIS AND ANALYSIS. Dichotomous
outcomes were expressed as relative risks (RRs) with
95% conﬁdence intervals (CIs). HRQL scores were
expressed as mean differences. Heterogeneity among
included studies was explored qualitatively and
quantitatively (using the chi-square test of hetero-
geneity and I2 statistic). Data from each study
were pooled using a conservative random effects
meta-analysis model.
The meta-analysis of each outcome was stratiﬁed
according to the duration of study follow-up (i.e., 6 to
12 months [short-term]; 13 to 36 months [medium-
term]; and >36 months [long-term]). Using the
longest follow-up, we stratiﬁed meta-analyses to
explore heterogeneity and examine potential treat-
ment effect modiﬁers. We tested 9 a priori hypotheses
that there may be differences in the effect of exercise-
based CR on outcomes at longest follow-up across the
TABLE 1 Summary of Trial and Patient Characteristics (63 Included Studies)
Study characteristics
Publication year
1970–1979 2 (3)
1980–1989 12 (19)
1990–1999 20 (32)
2000–2009 21 (33)
2010 onwards 8 (13)
Study location
Europe 37 (59)
North America 12 (19)
Asia 6 (10)
Australasia 5 (8)
Other 2 (3)
Not reported 1 (2)
Single center 45 (71)
Sample size 126 (28–2,304)
Duration of follow-up, months 12 (6–120)
Population characteristics
Sex
Males only 18 (29)
Females only 1 (2)
Both males and female 41 (65)
Not reported 3 (5)
Age, yrs 56.0 (49.3–71.0)
Diagnosis
Post-myocardial infarction only 31 (49)
Revascularization only 2 (3)
Angina only 5 (8)
Mixed CHD population 25 (40)
Intervention characteristics
Intervention type
Exercise-only programs 25* (38)
Comprehensive programs 39* (60)
Duration of intervention, months 6 (1–48)
Dose of intervention
Duration 6 months (1–48)
Frequency 1–7 sessions/week
Length 20–90 min/session
Intensity  50%–85% of maximal heart rate
 50%–95% of maximal oxygen uptake
(VO2 max)
 Borg rating of 11–15
Setting
Center-based only 33 (52)
Combination of center- and
home-based
13 (21)
Home-based only 15 (24)
Not reported 2 (3)
Values are number of studies (%) or median (range). Median of study means: *1 study includes
both exercise-only and comprehensive cardiac rehabilitation arms.
CHD ¼ coronary heart disease.
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4following subgroups: 1) CHD case mix (MI-only trials
vs. other trials); 2) type of CR (exercise-only CR vs.
comprehensive CR); 3) dose of exercise intervention
(dose ¼ number of weeks of exercise training 
average number of sessions/week  average duration
of session in minutes) (dose $1,000 U vs. dose<1,000 U); 4) follow-up period; 5) year of publication;
6) sample size; 7) setting (home- or center-based CR);
8) risk of bias (low risk of bias in <5 of 8 domains);
and 9) study location (continent).
The funnel plot and Egger test were used to
examine small-study bias (18). All statistical analyses
were performed using Review Manager 5.3 Software
(19) and STATA version 13.0 (StataCorp, College
Station, Texas) (20).
RESULTS
SELECTION AND INCLUSION OF STUDIES. The 2011
Cochrane review provided 47 RCTs (81 publications).
Our searches for this update yielded 11,028 titles, of
which 91 full papers were considered for inclusion.
Sixteen new RCTs (21 publications) were included,
giving a total of 63 studies (102 publications; see
Figure 1 for a summary of the study selection process
and Online Table 1 for a list of included studies).
STUDY, PATIENT, AND INTERVENTION CHARACTERISTICS.
Fourteen studies were published before 1999, and
49 have been published since 2000 (Table 1). The me-
dian follow-up was 12 months, with 50 studies
reporting at least 12 months of follow-up, and 18
reporting follow-up of 36 months or more. The major-
ity of studies were conducted in Europe (37 studies) or
North America (12 studies). Although we included
14,486 patients,most studieswere small in sample size
(median n ¼ 126; range 28 to 2,304), with 2 large
multicenter trials (WHO and RAMIT [Rehabilitation
After Myocardial Infarction Trial]) (12,21) contributing
a total of 4,177 patients (about 30% of all participants).
The median age of participants across studies was
56.0 years. Although 42 studies (66%) included
women, they accounted for <15% of all patients
recruited. Studies published since 2005 were less
dominated by post-MI patients, included other CHD
diagnoses (such as revascularization and angina), and
were more likely to include older (average mean age
61.7 years vs. 56.3 years) and female (20.0% vs. 12.5%)
participants.
Exercise-based CR programs were typically deliv-
ered in a supervised hospital/center-based setting,
either exclusively or in combination with some
maintenance home exercise sessions. Fifteen studies
were conducted in an exclusively home-based setting
(22–36). Whereas the primary mode of exercise
training across all studies was aerobic, the overall or
average duration, frequency, and intensity of ses-
sions varied considerably across studies. A total of 24
studies were exercise-only programs, 38 were
comprehensive CR, and 1 trial included both exercise-
only and comprehensive CR arms (37).
TABLE 2 Summary of Meta-Analysis Effects of Exercise-Based CR on Clinical Event Outcomes
Outcome
Number of Participants
(Number of Studies)
Number of Events/
Participants
RR (95% CI)
Statistical Heterogeneity I2
Statistic Chi-Square Test
(p Value)
GRADE Quality
of the EvidenceIntervention Comparator
All-cause mortality (all studies) 12,455 (47) 838/6,424 865/6,031 0.96 (0.88–1.04) 0% (0.58) þþþ
moderate*
Follow-up 6–12 months 8,800 (29) 226/4,573 238/4,227 0.88 (0.73–1.05) 0% (0.82)
Follow-up >12–36 months 6,823 (13) 338/3,495 417/3,328 0.89 (0.78–1.01) 0% (0.47)
Follow-up longer than 3 yrs 3,828 (11) 476/1,902 493/1,926 0.91 (0.75–1.10) 35% (0.12)
CV mortality (all studies) 7,469 (27) 292/3,850 375/3,619 0.74 (0.64–0.86) 0% (0.70) þþþ
moderate*
Follow-up 6–12 months 4,884 (15) 105/2,561 107/2,323 0.90 (0.69–1.17) 0% (0.72)
Follow-up >12–36 months 3,833 (7) 199/1,971 239/1,862 0.77 (0.63–0.93) 5% (0.38)
Follow-up longer than 3 yrs 1,392 (8) 56/690 100/702 0.58 (0.43–0.78) 0% (0.91)
Fatal and/or nonfatal MI (all studies) 9,717 (36) 356/4,951 387/4,766 0.90 (0.79–1.04) 0% (0.48) þþ
low*†
Follow-up 6–12 months 6,911 (20) 126/3,543 139/3,368 0.85 (0.67–1.08) 0% (0.58)
Follow-up >12–36 months 5,644 (11) 251/2,877 222/2,767 1.09 (0.91–1.29) 0% (0.72)
Follow-up longer than 3 yrs 1,560 (10) 65/776 102/784 0.67 (0.50–0.90) 0% (0.67)
CABG (all studies) 5,891 (29) 208/3,021 212/2,870 0.96 (0.80–1.16) 0% (0.86) þþþ
moderate*
Follow-up 6–12 months 4,563 (21) 123/2,351 121/2,212 0.99 (0.77–1.26) 0% (0.83)
Follow-up >12–36 months 2,755 (98) 122/1,379 123/1,376 0.98 (0.78–1.25) 0% (0.93)
Follow-up longer than 3 yrs 675 (4) 19/333 29/342 0.66 (0.34–1.27) 18% (0.30)
PCI (all studies) 4,012 (16) 171/2013 197/1999 0.85 (0.70–1.04) 0% (0.59) þþþ
moderate*
Follow-up 6–12 months 3,564 (13) 90/1,778 99/1,786 0.92 (0.64–1.33) 16% (0.30)
Follow-up >12–36 months 1,983 (6) 114/996 116/987 0.96 (0.69–1.35) 26% (0.24)
Follow-up longer than 3 yrs 567 (3) 28/281 37/286 0.76 (0.48–1.20) 0% (0.81)
Hospital admissions (all studies) 3,030 (15) 407/1,556 453/1,474 0.82 (0.70–0.96) 34.5% (0.10) þþ
low*†
Follow-up of 6–12 months 1,120 (9) 82/574 116/546 0.65 (0.46–0.92) 37% (0.14)
Follow-up >12–36 months 1,916 (6) 322/984 330/932 0.95 (0.84–1.07) 0% (0.50)
Follow-up longer than 3 yrs 0 (0) 0/0 0/0 Not estimable Not estimable
*Random sequence generation, allocation concealment, or blinding of outcome assessors were poorly described in >50% of included studies; bias likely. †Funnel plots and/or Egger test suggest evidence of
asymmetry. GRADE Working Group grades of evidence: high ¼ further research is very unlikely to change our conﬁdence in the estimate of effect; moderate ¼ further research is likely to have an important
effect on our conﬁdence in the estimate of effect and may change the estimate; low ¼ further research is very likely to have an important effect on our conﬁdence in the estimate of effect and is likely to
change the estimate. Very low quality: we are very uncertain about the estimate.
CABG ¼ coronary artery bypass graft; CI ¼ conﬁdence interval; CR ¼ cardiac rehabilitation; CV ¼ cardiovascular; MI ¼ myocardial infarction; PCI ¼ percutaneous coronary intervention; RR ¼ relative risk.
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5RISK OF BIAS AND GRADE ASSESSMENT. The overall
risk of bias across domains was judged to be low or
unclear (Online Table 2). Quality of reporting was
generally higher in more recent studies. Overall, the
GRADE (Grading of Recommendations Assessment,
Development and Evaluation) quality of evidence for
each outcome was assessed as low to moderate
(Table 2).
OUTCOME RESULTS. As there was no difference in
the effect of exercise-based CR on clinical outcomes
across length of follow-up (Table 2), the following
results focus on pooled ﬁndings across all trials at
their longest follow-up (median 12 months).
Morta l i ty . Forty-seven studies (n ¼ 12,455) reported
total mortality (Table 2, Figure 2). There was no sta-
tistically signiﬁcant reduction in total mortality with
exercise-based CR (RR: 0.96; 95% CI: 0.88 to 1.04)
compared with no-exercise control subjects. Twenty-seven studies (n ¼ 7,469) reported CV mortality
(Table 2, Central Illustration, Figure 3), and a statisti-
cally signiﬁcant reduction in this outcome was seen
with the no-exercise control subjects (RR: 0.74;
95% CI: 0.64 to 0.86). Twenty studies reported both
mortality outcomes. Results for mortality outcomes
in this subgroup were consistent with the overall
meta-analysis results (all-cause mortality RR: 0.91,
95% CI: 0.82 to 1.01; CV mortality RR: 0.78,
95% CI: 0.67 to 0.90).
Morbid i ty . Thirty-six studies (n ¼ 9,717) reported
the risk of fatal or nonfatal MI (Table 2, Online
Figure 1), and no statistically signiﬁcant difference
in the risk of total MI was found with exercise-based
CR (RR: 0.90; 95% CI: 0.79 to 1.04). Twenty-nine
(n ¼ 5,891), and 16 (n ¼ 4,012) studies reported the
risk of CABG and PCI, respectively (Table 2, Online
Figures 2 and 3). There was no difference between
FIGURE 2 Exercise-Based Rehabilitation Versus Usual Care: Total Mortality
Study
ID
Relative risk
random (95% CI)
Events,
Treatment
Events,
Control
Wilhelmsen 75
Kallio 79
Andersen 81
Sivarajan 82b
Carson 82
Sivarajan 82a
Bengtsson 83
WHO 83
Vermeulen 83
Roman 83
Stern 83
Erdman 86
Bethell 90
Fridlund 91
Leizorovicz (PRECOR) 91
Oldridge 91
Bertie 92
Schuler 92
Engblom 92
Heller 93
Fletcher 94
Holmback 94
Debusk 94
Haskell (SCRIP) 94
Carlsson 98
Bell 98
Stahle 99
Hofman-Bang 99
Dorn (NEHDP) 99
Toobert 00
Higgins 01
VHSG 03
Yu 04
Hambrecht 04
Montero 05
Briffa 05
Zwisler 08
Reid 11
West (RAMIT) 12
Mutwalli 12
Wang 12
Oerkild 12
Manchanda 00
Kovoor 06
Seki 08
Munk 09
Houle 12
Maddison 14
Overall (I-squared = 0.0%, p = 0.584)
0.79 (0.51, 1.24)
0.73 (0.51, 1.03)
1.22 (0.29, 5.12)
1.50 (0.16, 13.93)
0.58 (0.29, 1.13)
1.37 (0.15, 12.70)
1.85 (0.70, 4.87)
0.91 (0.75, 1.10)
0.43 (0.09, 2.13)
0.64 (0.37, 1.10)
0.23 (0.01, 5.52)
9.00 (0.50, 161.86)
1.37 (0.68, 2.76)
0.67 (0.31, 1.47)
0.11 (0.01, 2.05)
0.77 (0.18, 3.36)
0.13 (0.01, 2.52)
2.04 (0.19, 21.82)
0.85 (0.40, 1.77)
2.23 (0.56, 8.79)
0.86 (0.20, 3.62)
1.03 (0.07, 15.80)
1.20 (0.52, 2.72)
1.07 (0.22, 5.21)
0.99 (0.14, 6.91)
0.97 (0.44, 2.13)
1.58 (0.40, 6.28)
0.15 (0.02, 1.18)
1.09 (0.93, 1.28)
2.00 (0.09, 45.12)
2.73 (0.11, 65.43)
2.02 (0.19, 21.92)
0.55 (0.14, 2.12)
0.49 (0.05, 5.24)
0.44 (0.19, 1.01)
0.20 (0.01, 4.00)
1.16 (0.66, 2.03)
0.19 (0.01, 3.87)
1.02 (0.87, 1.18)
0.25 (0.01, 5.91)
0.33 (0.04, 3.14)
0.88 (0.28, 2.82)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
(Excluded)
0.96 (0.88, 1.04)
28/158
41/188
4/46
3/74
12/151
3/79
10/81
169/1208
2/47
16/93
0/42
4/40
16/113
9/87
0/60
3/99
0/57
2/56
12/119
6/213
3/41
1/34
12/293
3/145
2/113
19/251
5/56
1/46
162/315
1/17
1/54
2/98
4/132
1/51
7/90
0/57
24/227
0/115
245/903
0/28
1/80
4/19
0/21
0/72
0/18
0/20
0/32
0/85
838/6424
35/157
56/187
3/42
1/37
21/152
1/36
6/90
169/1096
5/51
27/100
1/29
0/40
12/116
14/91
4/61
4/102
3/53
1/57
13/109
3/237
4/47
1/35
10/292
3/155
2/112
8/102
3/53
6/41
150/319
0/11
0/49
1/99
4/72
2/50
16/90
2/56
20/219
2/108
243/910
1/21
3/80
5/21
0/21
0/70
0/16
0/20
0/33
0/86
865/6031
NOTE: Weights are from random effects analysis
.1 1 10
Favors CR Favors control
The boxes are proportional to the weight of each study in the analysis, and the lines represent their 95% conﬁdence intervals (CIs). The open diamond
represents the pooled relative risk, and its width represents its 95% CI. CR ¼ cardiac rehabilitation.
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6exercise CR and usual care for either CABG or PCI
(CABG: RR: 0.96, 95% CI: 0.80 to 1.16; PCI: RR: 0.85,
95% CI: 0.70 to 1.04). Fifteen studies (n ¼ 3,030)
reported hospital admissions (Table 2, Central
Illustration, Figure 3). Risk of admissions was reduced
with exercise-based CR compared with usual care
(RR: 0.82, 95% CI: 0.70 to 0.96, random effects). There
was no evidence of statistical heterogeneity acrosstrials in either mortality or morbidity outcomes (with
exception of hospitalizations) (I2 statistic: 35%).
Strat iﬁed meta-analyses . There was no evidence of
difference in CR versus control treatment effects ac-
ross mortality and morbidity outcomes across any pa-
tient, intervention, or study characteristics (Table 3).
Health-re la ted qua l i ty of l i fe . Twenty studies
(n ¼ 5,060) assessed HRQL using a range of validated
CENTRAL ILLUSTRATION Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease Versus Usual Care:
CV Mortality and Hospitalization
Anderson, L. et al. J Am Coll Cardiol. 2016; 67(1):1–12.
Box sizes are proportional to the weight of each study in the analysis, and the lines represent their 95% conﬁdence intervals (CIs). The open
diamond represents the pooled RR, and its width represents its 95% CI. CV ¼ cardiovascular.
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TABLE 3 Stratiﬁed Meta-Analysis by Patient, Intervention, and Study Characteristics at Longest Follow-Up
All-Cause Mortality CV Mortality MI CABG PCI Hospitalization
All studies 0.96 (0.88–1.04) 0.74 (0.64–0.86) 0.90 (0.79–1.04) 0.96 (0.80–1.16) 0.85 (0.70–1.04) 0.82 (0.70–0.96)
Case mix
100% MI 0.89 (0.78–1.01) 0.75 (0.65–0.87) 0.89 (0.76–1.05) 0.67 (0.45–1.00) 0.87 (0.67–1.15) 0.71 (0.41–1.24)
<100% MI 1.06 (0.92–1.22) 0.63 (0.38–1.06) 0.73 (0.44–1.23) 1.06 (0.86–1.31) 0.82 (0.58–1.15) 0.82 (0.68–0.99)
Dose of exercise*
<1,000 0.89 (0.26–3.15) 0.47 (0.19–1.15) 0.72 (0.30–1.70) 0.96 (0.35–2.66) 1.22 (0.34–4.34) 0.70 (0.48–1.00)
$1,000 1.01 (0.89–1.15) 0.75 (0.65–0.86) 0.74 (0.59–0.93) 0.99 (0.78–1.27) 0.80 (0.62–1.03) 0.85 (0.71–1.01)
Type of CR
Exercise only 0.94 (0.77–1.16) 0.65 (0.50–0.85) 0.76 (0.60–0.98) 0.98 (0.68–1.42) 0.87 (0.35–2.17) 0.61 (0.33–1.14)
Comprehensive CR 0.93 (0.841–1.03) 0.79 (0.66–0.94) 0.90 (0.72–1.14) 0.96 (0.77–1.19) 0.87 (0.71–1.07) 0.85 (0.72–1.00)
Duration of follow-up
#12 months 1.08 (0.51–2.33) 0.72 (0.62–0.84) 0.60 (0.39–0.91) 1.03 (0.74–1.44) 0.83 (0.54–1.27) 0.63 (0.46–0.88)
>12 months 0.96 (0.88–1.04) 1.00 (0.63–1.60) 0.92 (0.77–1.09) 0.93 (0.75–1.17) 0.84 (0.64–1.09) 0.92 (0.80–1.05)
Year of publication
Pre-1995 0.85 (0.75–0.98) 0.78 (0.67–0.91) 0.96 (0.81–1.14) 0.87 (0.59–1.30) 0.80 (0.42–1.51) 0.85 (0.69–1.05)
Post-1995 1.03 (0.903–1.14) 0.56 (0.38–0.83) 0.76 (0.59–0.99) 0.99 (0.81–1.22) 0.86 (0.70–1.06) 0.78 (0.60–1.00)
Setting
Center 0.91 (0.80–1.04) 0.75 (0.65–0.87) 0.96 (0.83–1.11) 0.97 (0.77–1.23) 0.90 (0.60–1.35) 0.89 (0.76–1.04)
Center þ home 0.78 (0.40–1.53) 0.67 (0.30–1.47) 0.40 (0.14–1.11) 0.79 (0.44–1.44) 0.65 (0.37–1.14) 0.83 (0.46–1.50)
Home 1.02 (0.68–1.54) 0.87 (0.34–2.20) 0.48 (0.28–0.83) 1.01 (0.59–1.7) 0.79 (0.53–0.18) 0.60 (0.33–1.05)
Risk of bias
Low (bias in <5 of 8 domains) 1.01 (0.88–1.17) 0.91 (0.22–3.74) 0.96 (0.69–1.33) 0.92 (0.69–1.21) 0.91 (0.70–1.18) 0.85 (0.61–1.20)
High (bias in >5 of 8 domains) 0.90 (0.80–1.02) 0.74 (0.64–0.86) 0.83 (0.69–1.00) 1.00 (0.79–1.28) 0.79 (0.59–1.06) 0.79 (0.65–0.97)
Study location, continent
Europe 0.90 (0.80–1.02) 0.73 (0.62–0.87) 0.93 (0.79–1.09) 0.94 (0.74–1.19) 0.85 (0.65–1.13) 0.72 (0.56–0.92)
North America 1.10 (0.94–1.27) 0.89 (0.56–1.43) 0.62 (0.41–0.94) 1.05 (0.78–1.42) 0.78 (0.52–1.16) 0.95 (0.81–1.11)
Australasia 0.85 (0.35–2.07) 0.33 (0.01–7.88) 1.90 (0.33–10.72) 0.32 (0.07–1.55) 0.99 (0.32–3.02) 1.07 (0.74–1.54)
Other 0.62 (0.36–1.07) 0.58 (0.32–1.08) 0.25 (0.01–5.91) NR NR 0.27 (0.10–0.74)
Sample size
#150 0.81 (0.51–1.29) 0.58 (0.33–1.00) 0.54 (0.35–0.83) 0.78 (0.53–1.16) 0.82 (0.47–1.42) 0.60 (0.46–0.78)
>150 0.95 (0.86–1.05) 0.76 (0.65–0.88) 0.93 (0.78–1.11) 1.02 (0.83–1.26) 0.87 (0.70–1.08) 0.93 (0.83–1.05)
Values are relative risk (95% conﬁdence interval). *Number of weeks of exercise training  average number of sessions/week  average duration of session in minutes.
NR ¼ not measurable; other abbreviations as in Table 2.
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8generic or disease-speciﬁc outcome measures (Online
Table 3). Given the heterogeneity in both outcome
measures and methods of reporting the ﬁndings, we
did not undertake meta-analysis. Fourteen of the 20
studies (65%) reported a higher level of HRQL in 1 or
more subscales following exercise-based CR compared
with control subjects (23,27,29,31,33,35,36,38–44), and
in 5 studies (25%), there was a higher level of HRQL in
one-half or more of the subscales (23,33,35,36,38).
Costs and cost-ef fect iveness . Seven studies re-
ported data on costs (31,40,45–49) (Online Table 4).
Three studies showed no difference in total health
care costs between CR and control groups (40,45,47),
1 reported lower health care costs for CR compared
with usual care (reduction of U.S. $2,378/patient)
(48), another reported higher health care costs for CR
(increase of U.S. $4,839/patient) (46), and 2 studies
did not report total health care costs (31,49).
Cost-effectiveness ranged from an additional U.S.$42,535/quality-adjusted life-year (40) for CR to a
reduction of U.S. $650/quality-adjusted life-year (47)
for CR compared with control subjects.
SMALL STUDY BIAS. There was no evidence of funnel
plot asymmetry or signiﬁcant Egger tests for mortal-
ity or revascularization outcomes (Online Figures 4
to 7). However, Egger tests were signiﬁcant for MI
(p ¼ 0.009) and hospitalization (p ¼ 0.001), indicating
funnel plot asymmetry. This asymmetry appeared to
be due to an absence of small- to medium-sized
studies with negative results for exercise-based CR
(Online Figures 8 and 9).
DISCUSSION
We conducted an updated systematic review and
meta-analysis of exercise-based CR in people with
existing CHD. Our study shows a reduction in pooled
CV mortality (10.4% to 7.6%; number needed to treat:
FIGURE 3 Exercise-Based Rehabilitation Versus Usual Care: Cardiovascular Mortality and Hospitalization
Exercise-based rehabilitation versus usual care: cardiovascular mortality 
Exercise-based rehabilitation versus usual care: hospitalization 
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Filled diamonds represent the relative risk for individual studies at the longest reported follow-up. The boxes are proportional to the weight of
each study in the analysis, and the lines represent their 95% conﬁdence interval (CIs). The open diamond represents the pooled relative risk,
and its width represents its 95% CI.
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1037), and hospital admission (30.7% to 26.1%; number
needed to treat: 22) with exercise-based CR compared
with no-exercise control subjects. There was no
between-group difference in total mortality or the
risk of fatal or nonfatal MI, CABG, or PCI. Outcome
effects were consistent across RCTs, irrespective
of patient case mix (i.e., % of MI patients), the
nature of the CR program (i.e., exercise-only or
comprehensive CR, dose of exercise training, or cen-
ter- or home-based settings), and study characteris-
tics (i.e., sample size, risk of bias, location, length
of follow-up, or year of publication). There was
evidence of higher levels of HRQL following exercise-
based CR compared with control subjects, and also
that exercise-based CR can be a cost-effective use of
health care resources.
In contrast to previous meta-analyses, we did
not observe a statistically signiﬁcant reduction in
all-cause mortality with exercise-based CR. This may
be explained by the inclusion of more recent studies
that include a more mixed population of CHD pa-
tients, conducted in the era of optimal medical
therapy for CHD. Our review included RCTs con-
ducted over a period (1974 to 2014) during which
there have been a number of major advances in
medical CHD management, such as the increased
use of statins. We found some support for this
hypothesis in our meta-regression analysis, which
shows a trend of a linear reduction (slope: 0.0063;
95% CI: 0.00150 to 0.0141; p ¼ 0.08) in the all-
cause mortality effect (log RR) of CR over time
(i.e., study publication date) (Online Figure 10).
Despite the observed improvements in CV mortality,
in a context of contemporary CHD medical treat-
ments, the opportunity for additional gains in over-
all mortality with exercise-based CR may be small.
Nonetheless, the observation that exercise-based CR
reduces the risk of CV mortality compared with no-
exercise control subjects, but does not reduce the
risk of MI or revascularization, suggests that
although CR does not improve coronary vascular
function or integrity, it does confer improved sur-
vival in patients post-MI.
STUDY LIMITATIONS. The generally poor level of
reporting in the included RCTs made it difﬁcult to
assess their methodological quality and thereby
judge their risk of bias. However, we did ﬁnd some
improvements in the quality of reporting in more
recently published studies. Reassuringly, the ﬁnd-
ings of our meta-analysis were consistent when
limited to studies with a lower risk of bias. Never-
theless, the general paucity of reporting led us to
downgrade the GRADE quality of evidence for
outcomes to low or moderate. We acknowledge thatthe median outcome follow-up of 12 months is
limited when assessing the effect on mortality and
morbidity outcome measures. However, our results
were consistent when pooling was limited to RCTs
with a follow up >12 months. Funnel plot asymmetry
for the risk of MI and hospital admission is indicative
of possible publication bias. Included RCTs did not
consistently report all outcomes relevant to this re-
view, and events were often reported in study de-
scriptions of dropout or withdrawal. Our results are,
therefore, on the basis of small and different subsets
of the overall RCT evidence base. However, we found
our overall meta-analysis results to be consistent in
the subgroup of 20 studies reporting both overall and
CV mortality outcomes. The minority of trials re-
ported non-CV causes of death. Only more recent
studies have begun to consistently report data on
hospitalizations, but still often fail to differentiate
between new and recurrent admissions, whereas
HRQL and cost data are still collected infrequently.
Finally, we sought to categorize the diagnoses of
study participants according to a more detailed
framework on the basis of Braunwald’s classiﬁcation
of CHD (50) to study whether the effect of
exercise-based CR differs according to the pre-
sentation, that is, acute coronary syndrome (MI,
non–ST-segment elevation MI, unstable angina pec-
toris) and stable angina pectoris or treatment mo-
dality (PCI, CABG, or medication alone). The limited
reporting by RCTs of inclusion and exclusion criteria
and participant characteristics prevented us from
applying this categorization. Nevertheless, we
believe this to be the most comprehensive review of
evidence to date, summarizing the results of RCTs in
>14,000 patients.
CONCLUSIONS
Among patients with established CHD, provision of
exercise-based CR provides important health beneﬁts
that include reductions in CV mortality and hospi-
talization (and associated health care costs) and im-
provements in HRQL. On the basis of a meta-analysis
of RCTs, these results support the Class I recom-
mendation of current international clinical guidelines
that CR should be offered to CHD patients. However,
future trials need to pay increased attention to
recruitment of patients who are more representative
of the broader CHD population, including those at
higher risk, with major comorbidities, and also with
stable angina. Future trials also need to improve their
quality of reporting, particularly in terms of risk of
bias, details of the intervention and control, clinical
events, HRQL, and health economic outcomes.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Exercise-based
CR reduces the risk of CV mortality and hospital admission and
improves HRQL in patients with CHD, independent of patient
characteristics, setting, or intervention.
COMPETENCY IN PATIENT CARE AND PROCEDURAL
SKILLS: Exercise-based CR is a safe and effective adjunct to
management of patients with CHD who are at low to moder-
ate risk following MI or revascularization and those with stable
angina.
TRANSLATIONAL OUTLOOK: Randomized trials should be
undertaken to evaluate CR in a broad population of patients with
CHD, including those with comorbidities who are at higher risk.
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